Analyses / Public Summary / 119 · HRES 1223 Public Summary

119-HRES-1223 Journalist Public Summary

119 · HRES 1223 Expressing support for the designation of Undiagnosed Awareness Month.

Plain‑language overview of H. Res. 1223 (introduced April 28, 2026): a bipartisan House resolution to recognize April as Undiagnosed Awareness Month and April 29 as Undiagnosed Day, explaining what it does, why it matters, who supports or questions it, and where it sits in the process.

Published
29 Apr 2026
Updated
29 Apr 2026
Tags
public-summary · health · awareness
Unvetted
01 · Section

Headline Summary

A bipartisan House resolution to recognize April as Undiagnosed Awareness Month and April 29 as Undiagnosed Day, spotlighting the challenges people face when their medical conditions remain without a diagnosis.

02 · Section

What It Does

H. Res. 1223 states that the House of Representatives supports the ideals and goals of Undiagnosed Awareness Month. It highlights the long, often costly path many families endure to get answers; recognizes work by the NIH’s Undiagnosed Diseases Network (UDN) and the patient‑led Undiagnosed Diseases Network Foundation (UDNF); and points to tools like genomic sequencing and emerging AI methods that can speed accurate diagnoses.

03 · Section

Why It Matters

  • Millions live with rare or undiagnosed conditions, often waiting years for answers. Delays can mean inappropriate care, psychological stress, and financial hardship.
  • Earlier, accurate diagnosis can help families plan treatment, avoid unnecessary procedures, and connect to research or support communities.
  • The resolution draws attention to U.S. efforts like the NIH’s UDN and the patient‑driven UDNF, and to expanding use of genomic testing and clinical expertise across more sites.
  • Awareness alone doesn’t guarantee access—coverage, workforce capacity, and research funding ultimately determine whether more people benefit.
Americans affected (rare/undiagnosed)
25000000people (approx.)
Typical diagnostic “odyssey”
7years (avg.)
UDN clinical sites in the U.S.
24sites
Diagnoses made via UDN since 2015 (minimum)
1000people
New/novel diagnoses identified (minimum)
90conditions
NIH target to expand UDN access by
2027year
04 · Section

Who’s For It

  • Lead sponsors: Rep. Mark Pocan (D‑WI), Rep. Ben Cline (R‑VA), Del. Eleanor Holmes Norton (D‑DC), Rep. John Rutherford (R‑FL) — signaling bipartisan support.
  • Supportive rationale from sponsors (as reflected in the text): honor patients and families living without answers; recognize clinicians and researchers; and encourage broader awareness and education to reduce delays in diagnosis.
05 · Section

Who’s Against It

  • No specific opponents are named in the resolution text.
  • Typical critiques of awareness resolutions: they are symbolic and can consume floor or committee time without delivering measurable policy changes; some argue effort should focus on funding diagnostic programs, insurer coverage for genomic testing, or building the clinical workforce.
06 · Section

What’s Next

As of April 28, 2026, the resolution has been submitted and referred to the House Committee on Oversight and Government Reform. Because it is a simple House resolution, it only requires House consideration; it does not go to the Senate or the President. It may be scheduled for committee or floor action, or it may see no further movement.

Bill type
Simple House resolution (nonbinding statement)
Introduced
April 28, 2026
Current status
Referred to the House Committee on Oversight and Government Reform
Scope
Recognizes April as Undiagnosed Awareness Month and April 29 as Undiagnosed Day

Discussion